Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Parkman Healthcare Partners LLC is named as a reporting person in SEC Form 4 filings. OQRO lists 3 transactions filed with the SEC under this name, the latest on Oct 9, 2025, each linked to the official Form 4.
Disclosures on record
3
Companies involved
1
Parkman Healthcare Partners LLC bought shares on the open market in 2025. Sales in 1 of the 2 years since 2025.
Parkman Healthcare Partners LLC reported 1 open-market purchase and 2 sales since 2025; purchases in 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $4.6K1×1 trade | $4.9K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
1 buy, median −58.2 pts vs S&P 500, beat it 0 of 1 time.
Average −58.2 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Oct 9, 2025 to Oct 9, 2025, measured from the first close after the filing. Past results, not a forecast.
Spruce BiosciencesSPRB
3 disclosures · Oct 2025 · 2 sold · 1 bought
Oct 6, 2025Bought~$4.6Kdisclosed Oct 9
DetailsOfficial recordOct 6, 2025Sold~$4.5Kdisclosed Oct 9
DetailsOfficial recordOct 6, 2025Sold~$436disclosed Oct 9
DetailsOfficial recordAs of the latest filing on , Parkman Healthcare Partners LLC reported holding 1,050 shares of Spruce Biosciences (SPRB), worth about $44K at the last close of $42 (Nov 16, 2026), held through a see footnote.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Spruce Biosciences SPRB | 1,050 | 1,050 see footnote | $42 | $44K | Oct 6, 2025 |
Is this Parkman Healthcare Partners LLC’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Oct 6, 2025, Parkman Healthcare Partners LLC reported holding 1,050 shares of Spruce Biosciences (SPRB), held indirectly. At the last close of $42 on Nov 16, 2026, that is about $44K. This is the stake disclosed in filings, not a net worth.
Parkman Healthcare Partners LLC bought shares on the open market in 2025. Sales in 1 of the 2 years since 2025.
In SEC filings since 2025: the latest open-market purchase is from 2025; the latest open-market sale is from 2025.
Spruce Biosciences (SPRB), from 2025 to 2025: 1 purchase and 2 sales.
Parkman Healthcare Partners LLC reported 1 open-market purchase and 2 sales here, 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.